Scorpion Capital
- Company typePrivate
- Founded2013
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
Scorpion Capital firmographics
Firmographics- Name
- Scorpion Capital
- Legal name
- Scorpion Capital LLC
- Website
- https://scorpioncapital.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Scorpion Capital industry classification
Industry- Product category
- Activist Short-Selling Research
- NAICS
- Portfolio Management and Investment Advice (523940), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Equity Research (FSACAGAA)
- akta.pro secondary industries
- Strategy & Thematic Research (FSACAGAG), Market Abuse & Conduct Risk (Insider Trading, Manipulation) (FSACAJAB), Research Compliance & Governance (FSACAGAK)
Keywords
Where Scorpion Capital is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Scorpion Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Short Selling Gains: Scorpion Capital generates profits through short positions in companies targeted by their research reports. The firm and its principals, members, partners, affiliates, employees, consultants, clients, investors, and related party entities hold short positions in companies that are the subject of their reports, allowing them to realize significant gains when stock prices decline.
Distribution channels1 record
Marketing channels5 records
Scorpion Capital product offering
Product offeringCore offering
Scorpion Capital publishes intensive, differentiated activist short-selling research reports (often 300-415 pages) that uncover publicly traded frauds and overhyped "promote" stocks. The firm's reports combine expert interviews, social media analysis, clinical trial data examination, and regulatory filing analysis to identify securities fraud, misleading corporate claims, data integrity issues, and safety concerns. Selected reports are accompanied by FDA Citizen Petitions alleging regulatory concerns about the target company.
Product overview
Scorpion Capital is an activist short-selling research firm that publishes differentiated, intensive investigative research reports targeting publicly traded frauds and promotes. The firm's primary offering consists of detailed research reports (often 300+ pages) on target companies, which are distributed via its website and accompanied by FDA Citizen Petitions when applicable. Reports are authored by Founder and CIO Kir Kahlon and include detailed case studies some of which are taught at Harvard Business School.
Differentiator
Problem solved
Functional benefit
Products and services
- Research Reports Intensive, differentiated activist short-selling research reports (typically 300-415 pages) that uncover publicly traded frauds and overhyped companies. Reports combine expert interviews, social media analysis, clinical trial data examination, and regulatory filing analysis, and are published for free download via the firm's website for institutional and individual investors.
- Newsletter Subscription Free email newsletter subscription service available on the Scorpion Capital website that allows investors and market participants to subscribe and receive upcoming research reports.
Quantifiable outcome
- Scorpion Capital's report on Soleno Therapeutics (August 15, 2025) caused the stock to decline 11.98% on publication and contributed to a total stock decline exceeding 50% during the August-November 2025 period
- +1 more outcomes
Companies that use Scorpion Capital
Customer profileIdeal customer profiles2 records
Scorpion Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Scorpion Capital partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Scorpion Capital competitors and assessment
Company assessmentDirect peers
- Hindenburg Research: Activist short-selling firm publishing forensic research reports on alleged corporate fraud; most direct comparable in business model, target universe (public equities), and revenue model (short P&L).
- Muddy Waters Research: Carson Block's activist short-seller publishing investigative reports on public companies; directly comparable in research-driven short-selling model and institutional investor audience.
- Citron Research: Andrew Left's long-running activist short/long research firm; competes in the same forensic short-research category with high-profile single-name reports.
- Spruce Point Capital Management: Activist short-focused investment firm publishing 'Spruce Point Reports' on alleged corporate misconduct; closely comparable in report-driven short thesis business.
- Iceberg Research: Activist short-seller publishing reports on suspected fraud and accounting irregularities; comparable in target universe and methodology.
- Grizzly Research: Forensic short-research firm publishing detailed reports on public companies alleged to be overhyped or fraudulent; similar differentiated, multi-page report style.
- Bonitas Research: Activist short-research firm with focus on alleged accounting fraud and disclosure issues; comparable in forensic equity research and short P&L model.
- Wolfpack Research: Activist short-research firm founded by Dan David, publishing forensic reports on public companies; comparable in business model and report-driven short thesis approach.
Emerging players
- Fuzzy Panda Research: Newer entrant in activist short research; partial overlap with Scorpion's methodology and target universe but with shorter track record.
- Kerrisdale Capital: Hedge fund with publicly distributed long and short investment theses; overlaps with Scorpion in publishing detailed public reports but also runs a long book.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Scorpion Capital social profiles
Digital presenceScorpion Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Scorpion Capital leadership team
Management profileNumber of profiles
Profiles1 record
Scorpion Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Scorpion Capital M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Scorpion Capital
What does Scorpion Capital do?
Scorpion Capital publishes intensive, differentiated activist short-selling research reports (often 300-415 pages) that uncover publicly traded frauds and overhyped "promote" stocks. The firm's reports combine expert interviews, social media analysis, clinical trial data examination, and regulatory filing analysis to identify securities fraud, misleading corporate claims, data integrity issues, and safety concerns. Selected reports are accompanied by FDA Citizen Petitions alleging regulatory concerns about the target company.
Is Scorpion Capital a public or private company?
Scorpion Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Scorpion Capital founded?
Scorpion Capital was founded in 2013. It employs 1 to 10 people.
Where is Scorpion Capital based?
Scorpion Capital is headquartered in New York, United States, in the North America region.
How does Scorpion Capital make money?
One revenue line is on record: short Selling Gains.
Who are Scorpion Capital's main competitors?
Direct peers on record are Hindenburg Research, Muddy Waters Research, Citron Research, Spruce Point Capital Management, Iceberg Research, Grizzly Research, Bonitas Research and Wolfpack Research. Emerging players are Fuzzy Panda Research and Kerrisdale Capital.
Does Scorpion Capital have an API?
No public API is recorded for Scorpion Capital.
What industry is Scorpion Capital in?
Scorpion Capital's product category is Activist Short-Selling Research. Its primary akta.pro industry code is FSACAGAA, Equity Research, with a secondary code of FSACAGAG, Strategy & Thematic Research. Its NAICS code is 523940 and its SIC code is 6282.